Skip to content

Enterprise value at other companies

Pfizer logo
PfizerPFE
$222.4B+9.2%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$958.05M+65.4%
CG Oncology logo
CG OncologyCGON
$5.69B+212%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$1.25B+502%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$1B+982%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$1.77B+1,855%

Other financials

Income statement

See full
Operating income-$39.6M-21.1%
Net income-$35.8M-19.1%
EPS (diluted)-$0.34+19.0%

Balance sheet

See full
Cash & equivalents$56.4M+14.3%
Total debt$3.3M+2.6%
Total equity$415.6M+89.1%
Total assets$436.8M+79.8%

Cash flow

See full
Operating cash flow-$32.4M+0.3%
CapEx$2.0K-99.5%
Free cash flow-$32.4M+1.5%

Valuation

See full
Market cap$976.17M+23.0%

Returns & leverage

See full
Return on equity-42.6%-4.6pp
Debt / equity0.0×
Current ratio16.3×+4.3×

Where this comes from

Calculated from Oric Pharmaceuticals, Inc.’s reported figures.

The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oric Pharmaceuticals, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oric Pharmaceuticals, Inc.'s enterprise value?
Oric Pharmaceuticals, Inc. (ORIC) reported enterprise value of $1.37B in Q1 2026.
How has Oric Pharmaceuticals, Inc.'s enterprise value changed year-over-year?
Oric Pharmaceuticals, Inc.'s enterprise value increased by 290.1% year-over-year, from $350.21M to $1.37B.
What is the long-term trend for Oric Pharmaceuticals, Inc.'s enterprise value?
Over 4 years (2021 to 2025), Oric Pharmaceuticals, Inc.'s enterprise value has grown at a 20.0% compound annual growth rate (CAGR), from $366.08M to $758.42M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.